The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels
Abstract
To investigate whether the effect of ABO blood group on plasma von Willebrand factor (vWF) levels is mediated by the ABH antigenic determinants carried on N -linked glycans of vWF, we studied 158 group A and group O healthy volunteers. vWF antigen (vWF:Ag) and factor VIII antigen (FVIII:Ag) levels were highest in A 1 A 1 individuals and higher in A 1 O 1 than in A 2 O 1 or O 1 O 1 individuals. Plasma A transferase activity and the amount of A antigen expressed per unit vWF ( AvWF ) were significantly higher in A 1 A 1 than in A 1 O 1 individuals and higher in A 1 O 1 than in A 2 O 1 individuals. AvWF was correlated strongly with plasma levels of A transferase activity. Thus, we have clearly demonstrated a direct relationship between ABO genotype, A transferase expression, and the amount of A antigen expressed on circulating vWF. H antigen expression per unit vWF ( HvWF ) was highest in group O individuals. Among group A individuals, the pattern of HvWF expression was A 2 O 1 > A 1 O 1 > A 1 A 1 . In group O and group A 2 O 1 individuals, HvWF was inversely correlated with plasma vWF levels. In contrast, among group A 1 A 1 and A 1 O 1 individuals, there was no relationship between AvWF and plasma vWF levels. These findings suggest that it is H antigen expression that mediates the ABO effect on plasma vWF concentration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These antigens can also be found on soluble molecules, platelets, some leukocytes, endothelium, and many different types of epithelial cells (Curtis et al., 2000; Liu and Wang, 2022; O'Donnell et al., 2002; Reid and Olsson, 2012).”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as O'Donnell et al., 2002
In the citing paper
“A, B, and H antigens can be found on vWF and may affect the circulating half-life of vWF”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as O'Donnell et al., 2002
In the citing paper
“Because the A and B glycosyltransferases are not 100% efficient, blood group A, B, and AB individuals also express some H antigen (Curtis et al., 2000; O'Donnell et al., 2002).”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as O'Donnell et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carbohydrate-Specific Receptors of the Liver
Ashwell, G., & Harford, J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002531 · Cited by 1,914
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131
Research works printed but not linked: 41
- 10.1182/blood.V57.6.1140.1140 · DOI · Paper page
- 10.1146/annurev.biochem.67.1.395 · DOI · Paper page
- 10.1182/blood.V70.4.895.895 · doi:10.1182/blood.v70.4.895.895
- 10.1111/j.1749-6632.1991.tb43700.x · doi:10.1111/j.1749-6632.1991.tb43700.x
- 10.1073/pnas.92.7.2455 · DOI
- Nichols WC, Ginsberg D. von Willebrand disease. Rev Mol Med. 1997; 76: 1–20.
- 10.1111/j.1365-2141.1994.tb05079.x · DOI · Paper page
- 10.1056/NEJM197112092852404 · DOI
- 10.1055/s-0037-1613748 · DOI · Paper page
- 10.1016/S0950-3536(05)80155-6 · DOI
- 10.1111/j.1365-2141.1964.tb00698.x · DOI · Paper page
- Orstavik K, Magnus P, Reisner H, Berg K, Graham J, Nance W. Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985; 37: 89–101.
- 10.1055/s-0038-1665305 · doi:10.1055/s-0038-1665305
- 10.1055/s-0038-1661121 · doi:10.1055/s-0038-1661121
- 10.1182/blood.V69.6.1691.1691 · DOI · Paper page
- 10.1111/j.1423-0410.1995.tb02579.x · doi:10.1111/j.1423-0410.1995.tb02579.x
- 10.1161/atvb.20.8.2024 · doi:10.1161/atvb.20.8.2024
- 10.1016/S0021-9258(19)50338-6 · DOI · Paper page
- Mohlke KL, Purkayastha AA, Westrik RJ, Smith PL, Petryniak B, Lowe JB, Ginsberg D. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell. 1998; 96: 111–120.
- 10.1046/j.1537-2995.1998.381098440863.x · DOI
- 10.1182/blood.V82.2.663.663 · DOI
- 10.1016/S0021-9258(19)86586-9 · DOI
- 10.1016/S0021-9258(18)42401-5 · DOI
- 10.1007/BF02346189 · DOI
- 10.1002/(SICI)1098-1004(1996)8:4<358::AID-HUMU9>3.0.CO;2-3 · doi:10.1002/(sici)1098-1004(1996)8:4<358::aid-humu9>3.0.co;2-3
- 10.1007/BF01355523 · DOI
- Brown SA, Bowen DJ, Ellis D, Collins PW. von Willebrand factor blood group-associated antigens: immunological detection and distribution. Blood. 1997; 90: 466a.Abstract.
- 10.1182/blood.V94.8.2895.420a03_2895_2900 · DOI
- 10.1055/s-0037-1614927 · DOI
- 10.1182/blood.V87.5.1809.1809 · DOI
- Eikenboom JC, Castaman G, Kamphuisen PW, Bertina RM. Factor VIII/von Willebrand factor in healthy controls and in heterozygous carriers of vWF null alleles and von Willebrand disease type 2N mutations. Thromb Haemost. 1999; 83: 686aAbstract.
- 10.1016/0049-3848(92)90097-T · doi:10.1016/0049-3848(92)90097-t
- 10.1182/blood.V96.4.1574 · DOI · Paper page
- Orntoft TF, Vestergaard EM, Holmes EH, Sinkbaek J, Wolf H. Influence of Lewis α1-3/4-L fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping and circulating tumor marker Sialyl-Lewis a levels. J Biol Chem. 1997; 271: 32260–32268.
- 10.1016/S0950-3536(05)80155-6 · DOI
- 10.1042/bj2990291 · DOI
- 10.1055/s-0038-1646295 · doi:10.1055/s-0038-1646295
- 10.1182/blood.V93.12.4277 · doi:10.1182/blood.v93.12.4277
- O’Donnell J Boulton FE Manning R Laffan M. Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level. Br J Haematol. In press.
- 10.1055/s-0038-1649589 · DOI · Paper page
- 10.1093/glycob/3.2.97 · DOI · Paper page
Cited by
Genome partitioning of genetic variation for complex traits using common SNPs
Yang, J., Manolio, T. A., Pasquale, L. R., Boerwinkle, E., Caporaso, N., Cunningham, J. M., de Andrade, M., Feenstra, B., Feingold, E., Hayes, M. G., et al. (2011) · Nature Genetics · doi:10.1038/ng.823 · Cited by 890
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins, P. V., & O’Donnell, J. S. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00975.x · Cited by 431
Self-citationTrégouët, D.-A., Heath, S., Saut, N., Biron-Andreani, C., Schved, J.-F., Pernod, G., Galan, P., Drouet, L., Zelenika, D., Juhan-Vague, I., et al. (2009) · Blood · doi:10.1182/blood-2008-11-190389 · Cited by 318
Update on Chronic Thromboembolic Pulmonary Hypertension
Lang, I. M., & Madani, M. (2014) · Circulation · doi:10.1161/circulationaha.114.009309 · Cited by 305
Gallinaro, L., Cattini, M. G., Sztukowska, M., Padrini, R., Sartorello, F., Pontara, E., Bertomoro, A., Daidone, V., Pagnan, A., & Casonato, A. (2008) · Blood · doi:10.1182/blood-2007-11-122945 · Cited by 298
Metadata
- Authors
- O’Donnell, J., Boulton, F. E., Manning, R. A., & Laffan, M. A.
- Affiliations
- From the Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, and the National Blood Service (F.E.B.), Southampton, UK.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2002-02
- Volume
- 22
- Issue
- 2
- Pages
- 335-341
- ISSN
- 1079-5642
- 1524-4636
- Cited by
- 125
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels. https://app.cochat.ai/papers/10.1161/hq0202.103997
- The paper
- O’Donnell, J., Boulton, F. E., Manning, R. A., & Laffan, M. A. (2002). Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/hq0202.103997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.